News
News from us and our partners
Tags
Topics
0 results
- News
Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia
- News
Biotalys Achieves Critical Manufacturing Milestone for First Commercial Biofungicide EVOCA® NG
- News
Polish AI Start-up Claims First Place on LongevityBench and Open-Sources a Version of its Thalamus Reasoning Model
- News
Tenpoint Therapeutics Launches the YUVEZZI™ Telehealth Prescribing Program
- News
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease
- News
AFYREN and MINASOLVE Announce Partnership Agreement to Jointly Develop Key Bio-Based Molecules for the Fragrances Industry at Industrial Scale
- News
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
- News
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition
- News
Biotalys’ First Commercial Biofungicide EVOCA® NG Approved for Large-Scale Commercial Field Trials in the Netherlands
- News
BrightHeart Expands Its AI Platform in Europe to Bring Greater Confidence and Consistency to Prenatal Ultrasound
- News
Sofinnova Partners promotes Javier Nunez-Vicandi to Partner, strengthening its Digital Medicine strategy
- News
Qorium Becomes Reyva as Cultivated Leather Company Moves Towards Commercial Scale
- News
Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome
- News
DMC secures $18M to expand health ingredients business
- News
CorWave completes enrollment in feasibility study and presents first clinical data on adaptive support with its Wave Membrane LVAD